BioEurope Spring – virtual

GenSight Biologics Reports Full Year 2020 Financial Results and provides an Outlook on 2021

Cell & Gene Meeting on the Mediterranean, virtual

GenSight Biologics Reports Cash Position as of December 31, 2020 and Provides Operational Update

GenSight Biologics Announces its 2021 Financial Calendar

39th Annual J.P. Morgan Healthcare Conference – Virtual

GenSight Biologics announces the partial conversion of convertible bonds and full exercise of share warrants by Kreos Capital

Bryan Garnier European Healthcare Conference 2020 – virtual event

GenSight Biologics reports validation of LUMEVOQ® Marketing Authorisation Application (MAA) by European Medicines Agency

Eyecelerator 2020 – Virtual Conference